Gastric endoscopy in the 21st century: Appropriate use of an invasive procedure in the era of non-invasive testing

Digestive and Liver Disease

Volumn 40, Issue 7, 2008, Pages 497-503

  Graham, D Y ^a   Kato, M ^b   Asaka, M ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Gastrin; Gastroscopy; Histology; Intestinal metaplasia; Pepsinogen

Indexed keywords

ANTIBIOTIC AGENT; GASTRIN; PEPSINOGEN; PROTON PUMP INHIBITOR;

CANCER RISK; CLINICAL PROTOCOL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; DISEASE SEVERITY; DISEASE SURVEILLANCE; ENDOSCOPIC BIOPSY; ERADICATION THERAPY; ESOPHAGUS DISEASE; GASTRITIS; GASTROINTESTINAL ENDOSCOPY; GASTROSCOPY; HEALTH PROGRAM; HELICOBACTER PYLORI; HUMAN; INVASIVE PROCEDURE; MEDICAL DECISION MAKING; NON INVASIVE MEASUREMENT; PREVALENCE; PROGNOSIS; RELIABILITY; SAMPLING; SHORT SURVEY; STOMACH BIOPSY; STOMACH CANCER; STOMACH MUCOSA; STOMACH ULCER; UREA BREATH TEST;

BIOPSY; GASTRITIS, ATROPHIC; GASTROSCOPY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PEPTIC ULCER; PREVALENCE; PROGNOSIS; SEVERITY OF ILLNESS INDEX; STOMACH NEOPLASMS;

EID: 44949113250     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2008.02.032     Document Type: Short Survey

References (26)

1. Wilber D.L. The history of diseases of the stomach and duodenum with reference also to their etiology. In: Eusterman G.B., and Balfour D.C. (Eds). The stomach and duodenum (1935), W.B. Saunders Company, Philadelphia 1-21
2. Rugge M., Meggio A., Pennelli G., Piscioli F., Giacomelli L., De P.G., et al. Gastritis staging in clinical practice: the OLGA staging system. Gut 56 (2007) 631-636
3. Graham D.Y., and Uemura N. Natural history of gastric cancer after Helicobacter pylori eradication in Japan: after endoscopic resection, after treatment of the general population, and naturally. Helicobacter 11 (2006) 139-143
4. Graham D.Y., and Shiotani A. The time to eradicate gastric cancer is now. Gut 54 (2005) 735-738
5. Sipponen P., and Graham D.Y. Importance of atrophic gastritis in diagnostics and prevention of gastric cancer: application of plasma biomarkers. Scand J Gastroenterol 42 (2007) 2-10
6. Miki K. Gastric cancer screening using the serum pepsinogen test method. Gastric Cancer 9 (2006) 245-253
7. nis-Ribeiro M., Yamaki G., Miki K., Costa-Pereira A., Matsukawa M., and Kurihara M. Meta-analysis on the validity of pepsinogen test for gastric carcinoma, dysplasia or chronic atrophic gastritis screening. J Med Screen 11 (2004) 141-147
8. Miki K., and Urita Y. Using serum pepsinogens wisely in a clinical practice. J Dig Dis 8 (2007) 8-14
9. El-Zimaity H.M., Ota H., Graham D.Y., Akamatsu T., and Katsuyama T. Patterns of gastric atrophy in intestinal type gastric carcinoma. Cancer 94 (2002) 1428-1436
10. Kimura K., and Takemoto T. An endoscopic recognition of the atrophic border and its significance in chronic gastritis. Endoscopy 1 (1969) 87-97
11. Kimura K. Chronological transition of the fundic-pyloric border determined by stepwise biopsy of the lesser and greater curvatures of the stomach. Gastroenterology 63 (1972) 584-592
12. Kimura K., Satoh K., Ido K., Taniguchi Y., Takimoto T., and Takemoto T. Gastritis in the Japanese stomach. Scand J Gastroenterol Suppl 214 (1996) 17-20
13. Kawachi T., Kogure K., Tanaka N., Tokunaga A., and Sugimura T. Studies of intestinal metaplasia in the gastric mucosa by detection of disaccharidases with "Tes-Tape". J Natl Cancer Inst 53 (1974) 19-30
14. Stemmermann G.N., and Hayashi T. Intestinal metaplasia of the gastric mucosa: a gross and microscopic study of its distribution in various disease states. J Natl Cancer Inst 41 (1968) 627-634
15. Rugge M., Correa P., Dixon M.F., Fiocca R., Hattori T., Lechago J., et al. Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading. Aliment Pharmacol Ther 16 (2002) 1249-1259
16. El-Zimaity H.M., and Graham D.Y. Evaluation of gastric mucosal biopsy site and number for identification of Helicobacter pylori or intestinal metaplasia: role of the Sydney system. Hum Pathol 30 (1999) 72-77
17. Graham D.Y., Shiotani A., and El-Zimaity H.M. Chromoendoscopy points the way to understanding recovery of gastric function after Helicobacter pylori eradication. Gastrointest Endosc 64 (2006) 686-690
18. Watabe H., Mitsushima T., Yamaji Y., Okamoto M., Wada R., Kokubo T., et al. Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study. Gut 54 (2005) 764-768
19. Maeda S., Yoshida H., Ogura K., Yamaji Y., Ikenoue T., Mitsushima T., et al. Assessment of gastric carcinoma risk associated with Helicobacter pylori may vary depending on the antigen used: CagA specific enzyme-linked immunoadsorbent assay (ELISA) versus commercially available H. pylori ELISAs. Cancer 88 (2000) 1530-1535
20. Ekstrom A.M., Held M., Hansson L.E., Engstrand L., and Nyren O. Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection. Gastroenterology 121 (2001) 784-791
21. Annibale B., Aprile M.R., D'Ambra G., Caruana P., Bordi C., and Delle F.G. Cure of Helicobacter pylori infection in atrophic body gastritis patients does not improve mucosal atrophy but reduces hypergastrinemia and its related effects on body ECL-cell hyperplasia. Aliment Pharmacol Ther 14 (2000) 625-634
22. Gutierrez O., Melo M., Segura A.M., Angel A., Genta R.M., and Graham D.Y. Cure of Helicobacter pylori infection improves gastric acid secretion in patients with corpus gastritis. Scand J Gastroenterol 32 (1997) 664-668
23. Iijima K., Sekine H., Koike T., Imatani A., Ohara S., and Shimosegawa T. Long-term effect of Helicobacter pylori eradication on the reversibility of acid secretion in profound hypochlorhydria. Aliment Pharmacol Ther 19 (2004) 1181-1188
24. El-Omar E.M., Oien K., El-Nujumi A., Gillen D., Wirz A., Dahill S., et al. Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology 113 (1997) 15-24
25. El-Zimaity H.M. Gastric atrophy, diagnosing and staging. World J Gastroenterol 12 (2006) 5757-5762
26. Japanese Gastric Cancer Association. Japanese Classification of Gastric Carcinoma, 2nd English Edition. Gastric Cancer 1998; 1:10-24.